Gil-Prieto, Ruth
Pérez, Jaime Jesus
Drago, Georgina
Kieffer, Alexia
Roïz, Julie
Kazmierska, Paulina
Sardesai, Aditya
de Boisvilliers, Solène
López-Belmonte, Juan Luis
Beuvelet, Matthieu
Aldean, Javier Alvarez
Funding for this research was provided by:
Sanofi
AstraZeneca
Article History
Received: 12 December 2023
Accepted: 23 July 2024
First Online: 6 September 2024
Declarations
:
: The study was based on publicly accessible anonymised databases (see ‘Availability of data and materials’ for full list of repositories), and thus is exempt from ethical compliance.
: Not applicable.
: RGP reports grants/honorarium from Sanofi, Merck, Pfizer, Moderna, Seqirus and GSK. JJP reports grants/personal fees from Sanofi. GD, AK, JLLB, and MB are employees of Sanofi and may hold shares and/or stock options in the company. JR, PK, AS, and SdB are employed by Evidera, a part of Thermo Fisher Scientific that receives funding for research from Sanofi. JAA reports grants/honorarium from Sanofi, Merck, Pfizer, GSK, and AstraZeneca.